According to the market research, the sales value of Rabeprazole in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the COVID-19 epidemic on the overall medical diagnosis and treatment services, the sales value decreased to CNY1.334 billion in 2020, with a year-on-year decrease of 11.01%. The CAGR of the sales value of Rabeprazole from 2016 to 2020 is 9.66% in China.
The analyst predicts that the sales of Rabeprazole will have a restorative growth from 2021 to 2025 with the effective alleviation of the Covid-19 epidemic. At the same time, only Rabeprazole injections among the six PPI injections listed in China are not listed in the national medical insurance catalog as of the first half of 2021. It may enter medical insurance in the future, prompting sales to continue to increase. In addition, Rabeprazole has no obvious individual differences. Rabeprazole has stabler efficacy and has less interaction with other drugs compared with similar drugs,. Based on these advantages, it is expected that the sales of Rabeprazole in the Chinese market will continue to rise from 2021 to 2025.
Topics Covered:
- The impact of COVID-19 on China's Rabeprazole market
- Sales value of China's Rabeprazole 2016-2020
- Competitive landscape of China's Rabeprazole market
- Prices of Rabeprazole in China
- Prices of Rabeprazole in China by regions and manufacturers
- Analysis of factors affecting the development of China's Rabeprazole market
- Prospect of China's Rabeprazole market from 2021 to 2025
Table of Contents
Samples
LOADING...
Companies Mentioned
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Nanjing Chang'ao Pharmaceutical Co., Ltd.
- Jichuan Pharmaceutical Group Co., Ltd.
- Eisai (China) Pharmaceutical Co., Ltd.
- Shandong Luoxin Pharmaceutical Group Co., Ltd.
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Nanjing Chang'ao Pharmaceutical Co., Ltd.
- Jichuan Pharmaceutical Group Co., Ltd.
- Eisai (China) Pharmaceutical Co., Ltd.
- Shandong Luoxin Pharmaceutical Group Co., Ltd.
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 50 |
Published | June 2021 |
Forecast Period | 2016 - 2025 |
Estimated Market Value ( CNY | CNY 922.68 Million |
Forecasted Market Value ( CNY | CNY 2351.09 Million |
Compound Annual Growth Rate | 10.9% |
Regions Covered | China |
No. of Companies Mentioned | 10 |